Answers are grounded in this paper and cite their sources.
The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT) is a rare complication of long-term lithium therapy (<100 cases reported), causing persistent neurologic deficits despite discontinuation. Typical features are cerebellar dysfunction, extrapyramidal signs, and cognitive decline. A 67-year-old man with bipolar I disorder on lithium for greater than 20 years presented with confusion, aphasia, and gait instability. The results of his imaging and infectious studies were unremarkable; his EEG showed generalized slowing. Despite lithium cessation, dialysis, and time in the intensive care unit, his neurologic function did not improve, with lithium rebound suggesting tissue redistribution. After 67 days in hospital, he remained severely impaired and dependent. This case meets SILENT criteria. The patient's prognosis is poor, underscoring the importance of strict lithium monitoring and early recognition of symptoms even with “normal” serum levels.
No takes yet. Share an insight, caveat, or question.
Anna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: